Editorial

» culture and infectious disease

Most Recent

image: Transparency Now

Transparency Now

By | May 1, 2016

Science is messy. So lay it out, warts and all.

1 Comment

image: Intelligence Gathering

Intelligence Gathering

By | July 1, 2015

Disease eradication in the 21st century

0 Comments

image: Hiding in the Haystack

Hiding in the Haystack

By | May 1, 2015

Encouraging developments in HIV research

0 Comments

image: Head Scratchers

Head Scratchers

By | September 1, 2014

Many natural phenomena elude our understanding.

5 Comments

image: The Next Big One

The Next Big One

By | June 1, 2013

As new infections surface and spread, science meets the challenges with ingenuity and adaptation.

2 Comments

image: A Chill Issue

A Chill Issue

By | February 1, 2013

The very cold, the merely chilled, and the colorful

0 Comments

image: Meeting of the Minds

Meeting of the Minds

By | July 1, 2012

New changes at The Scientist will ensure that we continue to showcase the best and brightest ideas in the life sciences.

1 Comment

image: Alive and Kicking

Alive and Kicking

By | October 1, 2011

The publication I launched a quarter century ago has come further than anyone ever expected.

27 Comments

image: Brave New Drugs

Brave New Drugs

By | January 1, 2011

Intoxicating ideas for saving a billion lives

0 Comments

Popular Now

  1. How Plants Evolved Different Ways to Make Caffeine
  2. Thomson Reuters Predicts Nobelists
    The Nutshell Thomson Reuters Predicts Nobelists

    According to citation statistics, researchers behind programmed cell death pathways and CRISPR/Cas9 are among those in line for Nobel Prizes this year.

  3. Monsanto Buys Rights to CRISPR
    The Nutshell Monsanto Buys Rights to CRISPR

    The US agribusiness secures a global, nonexclusive licensing agreement from the Broad Institute to use the gene-editing technology for agricultural applications.

  4. Reviewing Results-Free Manuscripts
    The Nutshell Reviewing Results-Free Manuscripts

    An open-access journal is trialing a peer-review process in which reviewers do not have access to the results or discussion sections of submitted papers.

RayBiotech